| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bfe01485020254ed73fd14f47e20880 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2014-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5243e4fcba4dbdaf26155e65d8054a73 |
| publicationDate |
2015-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015315655-A1 |
| titleOfInvention |
Prostate cancer testing and diagnosis method |
| abstract |
A molecular assay of prostate cancer testing and diagnosis method is provided. The tests of the present invention include a broad spectrum analysis of testing molecular values for prostate cancer management. The tests of the present invention may include a three part series of testing which includes distinguishing benign prostate hyperplasia from a potential prostate cancer diagnosis. The present invention further examines recurrent values for prostate cancer patients and in addition measures values for metastatic prostate cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111596069-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110009228-A |
| priorityDate |
2013-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |